OBJECTIVE: Postnatal angiogenesis relies on a proper response of endothelial cells to angiogenic stimuli. In systemic sclerosis (SSc), endothelial cells are unresponsive to angiogenic factors. Since circumstantial and experimental evidence points to tissue kallikreins as powerful effectors of the angiogenic response, we undertook this study to investigate the kallikrein pattern of normal and SSc endothelial cells in order to identify differences that can account for defective angiogenesis. METHODS: Expression of 14 tissue kallikreins was studied by a microarray approach, by reverse transcription-polymerase chain reaction, and by Western blotting in endothelial cells isolated from the skin of clinically healthy subjects and SSc patients. Cell proliferation was quantified by direct cell counting. Invasion and capillary morphogenesis were evaluated in a Boyden chamber and in culture flasks layered with Matrigel. Cyclic nucleotide production was measured by enzyme immunoassay. MAP kinase and ERK activation were measured by Western blotting. RESULTS: Endothelial cells from SSc patients showed poor expression of kallikreins 9, 11, and 12 compared with endothelial cells from normal subjects. Antibodies against the relevant kallikreins on normal endothelial cells revealed that while kallikreins 9, 11, and 12 induced cell growth, only kallikrein 12 regulated invasion and capillary morphogenesis. Buffering of kallikrein 12 with antibodies resulted in the acquisition of an SSc-like pattern by normal cells in in vitro angiogenesis. Reduction of cAMP and cGMP production and of ERK phosphorylation upon administration of antikallikrein antibodies revealed that the activity of kallikreins 9, 11, and 12 was mediated by kinins. CONCLUSION: Reduction of tissue kallikreins 9, 11, and 12 may be relevant to reduced angiogenesis in SSc patients.

The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis / B.GIUSTI; S.SERRATI'; F.MARGHERI; L.PAPUCCI; L.ROSSI; F.POGGI; A.MAGI; A.DEL ROSSO; M.CINELLI; S.GUIDUCCI; B.KAHALEH; M.MATUCCI CERINIC; R.ABBATE; G. FIBBI; M.DEL ROSSO. - In: ARTHRITIS AND RHEUMATISM. - ISSN 0004-3591. - STAMPA. - 52:(2005), pp. 3618-3628. [10.1002/art.21383]

The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis.

GIUSTI, BETTI;SERRATI', SIMONA;MARGHERI, FRANCESCA;PAPUCCI, LAURA;ROSSI, LUCIANA;MAGI, ALBERTO;DEL ROSSO, MARIO;CINELLI, MARINA;GUIDUCCI, SERENA;MATUCCI CERINIC, MARCO;ABBATE, ROSANNA;FIBBI, GABRIELLA;DEL ROSSO, ANGELA
2005

Abstract

OBJECTIVE: Postnatal angiogenesis relies on a proper response of endothelial cells to angiogenic stimuli. In systemic sclerosis (SSc), endothelial cells are unresponsive to angiogenic factors. Since circumstantial and experimental evidence points to tissue kallikreins as powerful effectors of the angiogenic response, we undertook this study to investigate the kallikrein pattern of normal and SSc endothelial cells in order to identify differences that can account for defective angiogenesis. METHODS: Expression of 14 tissue kallikreins was studied by a microarray approach, by reverse transcription-polymerase chain reaction, and by Western blotting in endothelial cells isolated from the skin of clinically healthy subjects and SSc patients. Cell proliferation was quantified by direct cell counting. Invasion and capillary morphogenesis were evaluated in a Boyden chamber and in culture flasks layered with Matrigel. Cyclic nucleotide production was measured by enzyme immunoassay. MAP kinase and ERK activation were measured by Western blotting. RESULTS: Endothelial cells from SSc patients showed poor expression of kallikreins 9, 11, and 12 compared with endothelial cells from normal subjects. Antibodies against the relevant kallikreins on normal endothelial cells revealed that while kallikreins 9, 11, and 12 induced cell growth, only kallikrein 12 regulated invasion and capillary morphogenesis. Buffering of kallikrein 12 with antibodies resulted in the acquisition of an SSc-like pattern by normal cells in in vitro angiogenesis. Reduction of cAMP and cGMP production and of ERK phosphorylation upon administration of antikallikrein antibodies revealed that the activity of kallikreins 9, 11, and 12 was mediated by kinins. CONCLUSION: Reduction of tissue kallikreins 9, 11, and 12 may be relevant to reduced angiogenesis in SSc patients.
52
3618
3628
B.GIUSTI; S.SERRATI'; F.MARGHERI; L.PAPUCCI; L.ROSSI; F.POGGI; A.MAGI; A.DEL ROSSO; M.CINELLI; S.GUIDUCCI; B.KAHALEH; M.MATUCCI CERINIC; R.ABBATE; G. FIBBI; M.DEL ROSSO
File in questo prodotto:
File Dimensione Formato  
21383_ftp.pdf

Accesso chiuso

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: DRM non definito
Dimensione 650.5 kB
Formato Adobe PDF
650.5 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2158/252150
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 58
  • ???jsp.display-item.citation.isi??? 53
social impact